Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Adma Biologics (ADMA) Interest & Investment Income: 2011-2024

Historic Interest & Investment Income for Adma Biologics (ADMA) over the last 11 years, with Dec 2024 value amounting to $2.1 million.

  • Adma Biologics' Interest & Investment Income fell 43.54% to $376,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year decrease of 6.11%. This contributed to the annual value of $2.1 million for FY2024, which is 29.68% up from last year.
  • As of FY2024, Adma Biologics' Interest & Investment Income stood at $2.1 million, which was up 29.68% from $1.6 million recorded in FY2023.
  • In the past 5 years, Adma Biologics' Interest & Investment Income ranged from a high of $2.1 million in FY2024 and a low of $35,000 during FY2021.
  • Over the past 3 years, Adma Biologics' median Interest & Investment Income value was $1.6 million (recorded in 2023), while the average stood at $1.3 million.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first plummeted by 87.85% in 2021, then spiked by 3,493.33% in 2023.
  • Adma Biologics' Interest & Investment Income (Yearly) stood at $288,126 in 2020, then plummeted by 87.85% to $35,000 in 2021, then climbed by 28.57% to $45,000 in 2022, then spiked by 3,493.33% to $1.6 million in 2023, then rose by 29.68% to $2.1 million in 2024.